Clorox — Form 10-Q Summary
Period clarification: The filing covers the quarter and nine months ended March 31, 2024 (Clorox fiscal Q3 and year-to-date FY2024), not calendar 2023 Q3. Dollar amounts are in millions except per-share data.
Business context and results
Clorox sells consumer and professional products across Health and Wellness, Household, Lifestyle and International. The filing describes operations as substantially normalized after the August 2023 cyberattack, though its sales and earnings impact continued.
| Metric | Three months ended Mar. 31, 2024 | Prior-year quarter | Nine months ended Mar. 31, 2024 | Prior-year period |
|---|---|---|---|---|
| Net sales | $1,814 | $1,915 | $5,190 | $5,370 |
| Gross profit | $766 | $800 | $2,164 | $2,046 |
| Gross margin | 42.2% | 41.8% | 41.7% | 38.1% |
| Net earnings (loss) attributable to Clorox | $(51) | $(211) | $64 | $(27) |
| Diluted EPS | $(0.41) | $(1.71) | $0.52 | $(0.22) |
| Segment adjusted EBIT (non-GAAP) | $260 | $269 | $737 | $623 |
| Operating cash flow | Not provided in the filing text for the quarter | Not provided in the filing text for the quarter | $355 | $728 |
Financial position, cash flow and segments
- Quarterly sales fell 5%; year-to-date sales fell 3%. Management cited lower shipments, distribution losses associated with the cyberattack, and weaker volumes. Pricing and mix partly offset volume declines.
- Gross margin improved 40 basis points for the quarter and 360 basis points year to date, mainly from pricing and cost savings; higher manufacturing and logistics costs, foreign exchange and, quarterly, trade promotion spending partly offset gains.
- Year-to-date operating cash flow was $355, down from $728, primarily reflecting higher tax and incentive-compensation payments and increased working capital. Capital expenditures were $131; dividends paid were $446.
- At March 31, cash and cash equivalents were $219; current assets were $1,661 versus current liabilities of $1,846. Notes and loans payable were $111 and long-term debt was $2,480. Clorox reported no borrowings under its $1,200 revolving credit agreement and compliance with its covenants.
- Year-to-date segment adjusted EBIT rose in Health and Wellness ($517 vs. $418) and International ($104 vs. $74), but declined in Household ($162 vs. $165) and Lifestyle ($192 vs. $217). Household and Lifestyle quarterly sales declined 4% and 11%, respectively; International quarterly sales increased 2%.
Material changes and unusual items
- Clorox sold its Argentina business on March 20, 2024. The sale produced a $240 pretax loss, primarily a noncash $223 release of accumulated currency-translation losses. The business contributed $43 of quarterly and $123 of year-to-date sales through the sale date.
- A domestic qualified pension-plan settlement generated a $171 pretax, primarily noncash charge in the nine-month period ($130 after tax).
- The prior-year comparable periods included $445 of noncash VMS goodwill and trademark impairments, which significantly affect year-over-year earnings comparisons.
- Cyberattack-related incremental costs were $8 for the quarter and $57 year to date. Clorox reported no insurance proceeds recognized for the incident as of the period end.
- Other items included $85 of year-to-date costs for digital capabilities and productivity enhancements, and a $16 gain on a warehouse sale-leaseback.
Outlook, management commentary and risks
- The filing does not provide a clear numerical FY2024 consolidated sales or earnings guidance value. Management expects a volatile, challenging operating environment, with inflationary pressure, consumer-spending uncertainty, commodity and logistics costs, and supply constraints remaining risks.
- Management expects cyberattack-related costs to lessen in future periods and said sales not recognized during the initial disruption were partly recovered in the second and third quarters. It nevertheless expects the attack to negatively affect FY2024 results.
- The streamlined operating model is expected to be completed in FY2024; management estimates eventual annual savings of approximately $75–$100 million. FY2024 restructuring costs were expected to be approximately $30–$40 million.
- Liquidity risks and uncertainties include cyber and IT disruption, inflation and supply-chain pressures, foreign exchange and geopolitical volatility, competition, and dependence on major customers. Walmart represented 25% of sales in the quarter and year to date.
- Environmental remediation liabilities totaled $28. Clorox noted that requirements or costs could change; it also disclosed other legal proceedings but said their ultimate disposition was not expected to materially affect the financial statements. Supplier-finance obligations included in accounts payable were $208.
Important facts for investors to verify
- Confirm the period being analyzed: this is FY2024 Q3, despite the request metadata stating 2023 Q3.
- Track whether cyber-related distribution losses, sales recovery and remediation costs continue to improve, and whether any insurance recovery is recognized.
- Separate recurring operating performance from the Argentina divestiture loss, pension settlement, prior-year VMS impairment and management-adjusted EBIT exclusions.
- Assess the sustainability of margin recovery and cash generation given lower volumes, higher costs, tax-payment timing and dividend outflows.
- Monitor execution and realized savings from the operating-model and digital investments, as well as environmental remediation exposure and customer concentration.